Neil Gallagher Syndax Pharmaceuticals Inc (SNDX) insider trading activity

SNDX Quotes by TradingView

Neil Gallagher is President, Head of R&D of Syndax Pharmaceuticals Inc. Currently has a direct ownership of 85,095 shares of SNDX, which is worth approximately $1.39 Million. The most recent transaction as insider was on Feb 10, 2025, when has been sold 4,618 shares (Common Stock) at a price of $15.5 per share, resulting in proceeds of $71,579. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 85.1K
77.97% 3M change
77.97% 12M change
Total Value Held $1.39 Million

Neil Gallagher Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 10 2025
SELL
Open market or private sale
$71,579 $15.5 p/Share
4,618 Reduced 5.15%
85,095 Common Stock
Feb 05 2025
BUY
Grant, award, or other acquisition
-
41,900 Added 31.84%
89,713 Common Stock
Feb 07 2024
BUY
Grant, award, or other acquisition
-
47,813 Added 50.0%
47,813 Common Stock

Also insider at

ZYME
Zymeworks Inc.
NG

Neil Gallagher

President, Head of R&D
Waltham, MA

Track Institutional and Insider Activities on SNDX

Follow Syndax Pharmaceuticals Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SNDX shares.

Notify only if

Insider Trading

Get notified when an Syndax Pharmaceuticals Inc insider buys or sells SNDX shares.

Notify only if

News

Receive news related to Syndax Pharmaceuticals Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SNDX